Methods of treating or preventing amyloid related imaging abnormalities associated with alzheimer's disease treatment
AssigneeBiogen Chesapeake LLC
InventorsSven JACOBSON, Thomas MACALLISTER
Life of this patent
Estimating the term…
Abstract
A method of treating or preventing amyloid related imaging abnormalities (ARIA) in patients receiving one or more course of medical treatment for Alzheimer's Disease includes administrating a SUR1-TRPM4 channel inhibitor, such as glyburide, in an amount effective to prevent the formation or reduce the size of one or more ARIAs in the brain.
Claims17
A method of treating or preventing amyloid related imaging abnormalities (ARIA) in a subject undergoing at least one course of medical treatment for Alzheimer's Disease, comprising administering a SUR1-TRPM4 channel inhibitor to the subject, wherein the SUR1-TRPM4 channel inhibitor is administered in an amount effective to prevent the formation or reduce the size of one or more ARIAs in the brain.
Dependencies are inferred from the claim text.